Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Neuroplasticity via neuronal synchronization" refers to the phenomenon where **coordinated timing of action potentials across networks of neurons facilitates changes in synaptic strength**, thereby enabling learning, memory formation, sensory integration, and adaptive behavior. This process involves multiple mechanisms including chemical synapses (neurotransmitter-mediated), electrical coupling through gap junctions among inhibitory interneurons—especially GABAergic cells—and modulation by myelination which ensures precise timing across distributed networks[1][2]. Synchronous firing patterns are thought to be essential for binding together different features into unified percepts ("binding hypothesis") and for efficient information transfer within cortical circuits[3]. Pathologically increased or decreased neural synchronization has been implicated in epilepsy, neurodegenerative diseases such as Alzheimer's disease, psychiatric disorders like schizophrenia, and stroke outcomes[4][1]. This term does **not refer to any single protein/gene/receptor**, but rather describes an emergent property arising from interactions among many cellular components—including voltage-gated ion channels responsible for action potentials,[3] gap junction proteins forming electrical synapses,[2] neurotransmitter receptors at chemical synapses,[7] myelin-related proteins influencing conduction velocity,[1] etc.—and their collective impact on brain function. > “The temporal control of information through action potential propagation along axons is a crucial mechanism for synaptic plasticity... Enhancing chemical and electromagnetic synchronization is crucial for brain evolution.” [1] > “The ‘synchrony through synaptic plasticity’ hypothesis explains how synchronous cell assemblies could emerge through correlated changes in synaptic efficacies...” [2] In summary: This entry should be considered *a biological phenomenon/process*, not an individual therapeutic target amenable to direct pharmacologic modulation without reference to its underlying molecular mediators.
Not applicable to this entry directly. For drugs that affect related processes: - Modulation of synaptic transmission - Alteration of ion channel function - Enhancement/inhibition of GABAergic signaling affecting network oscillations
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuroplasticity via neuronal synchronization (None established; this is not a standard molecular or receptor abbreviation.).